What we have is accompanying info on the PR for inclusion in the Russell Indices “Following our recently completed institutional equity financing "We are pleased to be added to these Russell indices, another important milestone in improving our visibility among the investment community," said Paul K. Wotton Ph.D., President and CEO of Ocata Therapeutics, who added “Following our recently completed institutional equity financing, we are well-positioned to initiate our phase 2 clinical trial for dry-AMD and our pivotal trial for SMD, both debilitating disease states with no effective therapeutic options and where we are dedicated to bringing these important therapies to patients in need.” http://ir.ocata.com/press-releases/detail/2785/ocata-therapeutics-added-to-russell-2000-3000-global-and I would expect there would be a follow up SEC filing in the very near future for the completed institutional equity financing.